Barclays raised the firm’s price target on Corebridge (CRBG) to $36 from $34 and keeps an Equal Weight rating on the shares. The company’s operating earnings comes in ahead of estimates on strong performance from Life Insurance and solid results in all other segments, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter